Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cervix Uteri | 5 | 2008 | 21 | 1.180 |
Why?
|
| Spinal Cord | 14 | 2006 | 139 | 0.780 |
Why?
|
| Morphine | 5 | 2008 | 57 | 0.720 |
Why?
|
| Pain | 5 | 2010 | 282 | 0.690 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2015 | 747 | 0.640 |
Why?
|
| Neurons, Afferent | 3 | 2008 | 54 | 0.610 |
Why?
|
| Analgesics, Opioid | 6 | 2015 | 239 | 0.590 |
Why?
|
| Estrogens | 3 | 2007 | 162 | 0.580 |
Why?
|
| TRPV Cation Channels | 2 | 2007 | 19 | 0.580 |
Why?
|
| Rats | 17 | 2015 | 1604 | 0.560 |
Why?
|
| Clonidine | 10 | 2004 | 60 | 0.530 |
Why?
|
| Injections, Spinal | 16 | 2015 | 124 | 0.480 |
Why?
|
| Adrenergic alpha-Agonists | 7 | 2004 | 41 | 0.440 |
Why?
|
| Animals | 33 | 2015 | 7297 | 0.400 |
Why?
|
| Physical Stimulation | 7 | 2015 | 84 | 0.400 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2015 | 39 | 0.380 |
Why?
|
| Hyperalgesia | 3 | 2015 | 88 | 0.370 |
Why?
|
| Ganglia, Spinal | 2 | 2008 | 63 | 0.350 |
Why?
|
| Pain Measurement | 7 | 2015 | 364 | 0.350 |
Why?
|
| Ketorolac | 4 | 2015 | 24 | 0.340 |
Why?
|
| Labor, Obstetric | 2 | 2008 | 31 | 0.330 |
Why?
|
| Labor Pain | 1 | 2008 | 8 | 0.330 |
Why?
|
| Pain, Postoperative | 3 | 2006 | 174 | 0.330 |
Why?
|
| Uterus | 3 | 2004 | 73 | 0.320 |
Why?
|
| Models, Animal | 1 | 2008 | 160 | 0.310 |
Why?
|
| Dilatation, Pathologic | 1 | 2007 | 19 | 0.310 |
Why?
|
| Analgesics | 3 | 2004 | 126 | 0.300 |
Why?
|
| Female | 32 | 2019 | 18164 | 0.300 |
Why?
|
| Behavior, Animal | 2 | 2008 | 264 | 0.290 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2006 | 8 | 0.280 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2006 | 8 | 0.280 |
Why?
|
| Somatostatin | 1 | 2006 | 10 | 0.280 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2006 | 41 | 0.280 |
Why?
|
| Hypothermia, Induced | 1 | 2005 | 16 | 0.270 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2005 | 7 | 0.270 |
Why?
|
| Interleukin-1 | 1 | 2005 | 33 | 0.270 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2005 | 9 | 0.260 |
Why?
|
| Neostigmine | 6 | 1996 | 16 | 0.260 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2004 | 4 | 0.250 |
Why?
|
| Cyclopropanes | 1 | 2004 | 19 | 0.250 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 980 | 0.250 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 200 | 0.240 |
Why?
|
| Genes, fos | 1 | 2003 | 4 | 0.230 |
Why?
|
| Posterior Horn Cells | 1 | 2003 | 11 | 0.230 |
Why?
|
| Piperidines | 3 | 2015 | 125 | 0.230 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 74 | 0.230 |
Why?
|
| Hemodynamics | 7 | 2004 | 148 | 0.220 |
Why?
|
| Acetylcholine | 7 | 2001 | 47 | 0.200 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2000 | 9 | 0.200 |
Why?
|
| Analgesia, Epidural | 3 | 1996 | 50 | 0.190 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 481 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 1 | 2000 | 62 | 0.190 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 14 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2015 | 641 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 96 | 0.180 |
Why?
|
| Anesthesia | 2 | 2019 | 65 | 0.180 |
Why?
|
| Hindlimb | 3 | 2008 | 57 | 0.180 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 70 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 72 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 77 | 0.170 |
Why?
|
| Cytokine-Induced Killer Cells | 1 | 2018 | 1 | 0.170 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 10 | 0.170 |
Why?
|
| Clinical Competence | 2 | 2019 | 307 | 0.170 |
Why?
|
| Hot Temperature | 4 | 2015 | 71 | 0.170 |
Why?
|
| Nitric Oxide | 5 | 1997 | 116 | 0.160 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 519 | 0.160 |
Why?
|
| Alfentanil | 1 | 1997 | 3 | 0.150 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1997 | 6 | 0.150 |
Why?
|
| Amitriptyline | 1 | 1997 | 7 | 0.150 |
Why?
|
| Sheep | 15 | 1999 | 221 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 162 | 0.150 |
Why?
|
| Skin | 2 | 2018 | 203 | 0.150 |
Why?
|
| Afferent Pathways | 2 | 2008 | 23 | 0.150 |
Why?
|
| Ephedrine | 2 | 1996 | 3 | 0.140 |
Why?
|
| Cholinesterase Inhibitors | 1 | 1996 | 29 | 0.140 |
Why?
|
| Norepinephrine | 4 | 1997 | 73 | 0.140 |
Why?
|
| Certification | 1 | 2016 | 24 | 0.140 |
Why?
|
| Capsaicin | 3 | 2010 | 30 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 326 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 6 | 0.130 |
Why?
|
| Adult | 10 | 2018 | 8420 | 0.130 |
Why?
|
| Umbilical Cord | 1 | 2015 | 8 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2016 | 111 | 0.130 |
Why?
|
| Anesthesiology | 1 | 2016 | 49 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2015 | 16 | 0.130 |
Why?
|
| Oxytocin | 1 | 2015 | 22 | 0.130 |
Why?
|
| China | 3 | 2020 | 44 | 0.120 |
Why?
|
| Pregnancy | 6 | 2008 | 815 | 0.120 |
Why?
|
| Male | 16 | 2019 | 17807 | 0.120 |
Why?
|
| Nociceptors | 2 | 2012 | 41 | 0.120 |
Why?
|
| Wound Healing | 1 | 2015 | 182 | 0.120 |
Why?
|
| Metaraminol | 2 | 1996 | 2 | 0.120 |
Why?
|
| Catheterization | 2 | 2004 | 58 | 0.120 |
Why?
|
| Pregnancy, Animal | 2 | 2008 | 19 | 0.120 |
Why?
|
| Stroke | 1 | 2019 | 545 | 0.120 |
Why?
|
| Naloxone | 2 | 2012 | 23 | 0.110 |
Why?
|
| Psoriasis | 1 | 2018 | 334 | 0.110 |
Why?
|
| Endothelium, Vascular | 3 | 1996 | 145 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 161 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1994 | 71 | 0.110 |
Why?
|
| Humans | 16 | 2020 | 29093 | 0.110 |
Why?
|
| Uterine Contraction | 1 | 1992 | 7 | 0.110 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 250 | 0.110 |
Why?
|
| Opioid Peptides | 1 | 2012 | 28 | 0.110 |
Why?
|
| Action Potentials | 3 | 2008 | 174 | 0.100 |
Why?
|
| Time Factors | 3 | 2019 | 2001 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2015 | 608 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 4 | 1996 | 36 | 0.090 |
Why?
|
| Nesting Behavior | 1 | 2008 | 3 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2008 | 24 | 0.080 |
Why?
|
| Injections, Intravenous | 3 | 2004 | 73 | 0.080 |
Why?
|
| Analgesia, Obstetrical | 1 | 2008 | 47 | 0.080 |
Why?
|
| Stimulation, Chemical | 3 | 2015 | 12 | 0.080 |
Why?
|
| Imidazoles | 5 | 1999 | 104 | 0.070 |
Why?
|
| Drug Interactions | 2 | 1997 | 80 | 0.070 |
Why?
|
| Administration, Cutaneous | 1 | 2006 | 107 | 0.070 |
Why?
|
| Cyclooxygenase 1 | 1 | 2006 | 23 | 0.070 |
Why?
|
| Taurocholic Acid | 1 | 2005 | 1 | 0.070 |
Why?
|
| Amylases | 1 | 2005 | 2 | 0.070 |
Why?
|
| Cholagogues and Choleretics | 1 | 2005 | 4 | 0.070 |
Why?
|
| Edema | 1 | 2005 | 30 | 0.070 |
Why?
|
| Analgesia | 2 | 1996 | 33 | 0.070 |
Why?
|
| Lipase | 1 | 2005 | 28 | 0.070 |
Why?
|
| Organ Size | 1 | 2005 | 196 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 1108 | 0.060 |
Why?
|
| Neurons | 1 | 2008 | 394 | 0.060 |
Why?
|
| Pancreas | 1 | 2005 | 79 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 239 | 0.060 |
Why?
|
| Rectum | 1 | 2004 | 15 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 35 | 0.060 |
Why?
|
| Electromyography | 1 | 2004 | 58 | 0.060 |
Why?
|
| Nerve Block | 1 | 2004 | 48 | 0.060 |
Why?
|
| Colon | 1 | 2004 | 56 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2004 | 147 | 0.060 |
Why?
|
| Succinate Dehydrogenase | 1 | 2003 | 3 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 71 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 32 | 0.060 |
Why?
|
| Dioxanes | 5 | 1996 | 6 | 0.060 |
Why?
|
| Idazoxan | 5 | 1996 | 10 | 0.060 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 1996 | 27 | 0.060 |
Why?
|
| Survival Rate | 1 | 2005 | 795 | 0.060 |
Why?
|
| Middle Aged | 4 | 2019 | 10829 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 863 | 0.050 |
Why?
|
| Young Adult | 3 | 2015 | 2402 | 0.050 |
Why?
|
| Cholinergic Fibers | 1 | 2001 | 7 | 0.050 |
Why?
|
| Diencephalon | 1 | 2000 | 1 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 3 | 1996 | 32 | 0.050 |
Why?
|
| Regional Blood Flow | 4 | 2004 | 82 | 0.050 |
Why?
|
| Seizures | 1 | 2000 | 61 | 0.050 |
Why?
|
| Hospitals | 1 | 2020 | 89 | 0.040 |
Why?
|
| Indans | 1 | 1999 | 25 | 0.040 |
Why?
|
| Neurotransmitter Agents | 2 | 1997 | 26 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2019 | 61 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 257 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2018 | 78 | 0.040 |
Why?
|
| Receptors, Muscarinic | 2 | 1995 | 10 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 881 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 1997 | 7 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 540 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 469 | 0.040 |
Why?
|
| Injections, Epidural | 1 | 1996 | 9 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 1996 | 11 | 0.040 |
Why?
|
| Potassium Chloride | 2 | 1996 | 4 | 0.040 |
Why?
|
| Life Style | 1 | 2019 | 364 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 787 | 0.040 |
Why?
|
| Parasympathetic Nervous System | 1 | 1996 | 2 | 0.040 |
Why?
|
| Nausea | 1 | 1996 | 49 | 0.040 |
Why?
|
| Sympathomimetics | 1 | 1996 | 4 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 1996 | 40 | 0.040 |
Why?
|
| Pain Threshold | 2 | 2008 | 95 | 0.040 |
Why?
|
| Narcotic Antagonists | 2 | 2012 | 50 | 0.030 |
Why?
|
| Aged | 2 | 2019 | 9487 | 0.030 |
Why?
|
| Computers | 1 | 1995 | 17 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 62 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 1995 | 29 | 0.030 |
Why?
|
| Epidermis | 1 | 2015 | 23 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 92 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2016 | 134 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 726 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 85 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 159 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1994 | 12 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 281 | 0.030 |
Why?
|
| DNA | 1 | 2015 | 204 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 501 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 1993 | 21 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 1305 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 1992 | 3 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2015 | 799 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 436 | 0.030 |
Why?
|
| Hypotension | 1 | 1993 | 47 | 0.030 |
Why?
|
| Shock | 1 | 1992 | 28 | 0.030 |
Why?
|
| Fetus | 1 | 1992 | 78 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1996 | 804 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1992 | 95 | 0.030 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 51 | 0.030 |
Why?
|
| Carbachol | 1 | 1991 | 7 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 3531 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3099 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2010 | 46 | 0.020 |
Why?
|
| Microdialysis | 2 | 2001 | 33 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2108 | 0.020 |
Why?
|
| Hypogastric Plexus | 1 | 2008 | 5 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 66 | 0.020 |
Why?
|
| United States | 1 | 2016 | 3630 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2006 | 64 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 172 | 0.020 |
Why?
|
| Pirenzepine | 2 | 1995 | 2 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 2004 | 6 | 0.020 |
Why?
|
| Hematocrit | 1 | 2004 | 23 | 0.020 |
Why?
|
| Spinal Cord Compression | 1 | 2004 | 8 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2004 | 55 | 0.020 |
Why?
|
| Dogs | 1 | 2004 | 117 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2006 | 514 | 0.020 |
Why?
|
| Bupivacaine | 1 | 2004 | 48 | 0.020 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 77 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 290 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 3254 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2001 | 25 | 0.010 |
Why?
|
| Fluorobenzenes | 1 | 2001 | 19 | 0.010 |
Why?
|
| Fluorine Radioisotopes | 1 | 2001 | 21 | 0.010 |
Why?
|
| Inflammation | 1 | 2004 | 507 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1999 | 16 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2001 | 322 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 4 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 462 | 0.010 |
Why?
|
| Femoral Nerve | 1 | 1996 | 6 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1996 | 6 | 0.010 |
Why?
|
| Microchemistry | 1 | 1996 | 5 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 18 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 17 | 0.010 |
Why?
|
| Dialysis | 1 | 1996 | 3 | 0.010 |
Why?
|
| Hemoglobins | 1 | 1996 | 42 | 0.010 |
Why?
|
| Vasodilation | 1 | 1996 | 87 | 0.010 |
Why?
|
| Fentanyl | 1 | 1996 | 33 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 60 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1996 | 102 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 162 | 0.010 |
Why?
|
| Respiration | 1 | 1995 | 26 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1995 | 86 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1994 | 7 | 0.010 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1994 | 4 | 0.010 |
Why?
|
| Aorta | 1 | 1994 | 103 | 0.010 |
Why?
|
| Medetomidine | 1 | 1993 | 2 | 0.010 |
Why?
|
| Dopamine | 1 | 1996 | 226 | 0.010 |
Why?
|
| Basilar Artery | 1 | 1992 | 10 | 0.010 |
Why?
|
| Catecholamines | 1 | 1992 | 17 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1992 | 44 | 0.010 |
Why?
|